About 64 results
Open links in new tab
  1. https://www.proair.com/globalassets/respiclick/images ...

    ProAir RespiClick ® (albuterol sulfate) Inhalation Powder is a prescription medicine used in people 4 years of age and older to: treat or prevent bronchospasm in people who have reversible obstructive …

  2. ProAir RespiClick - HCP Official Website

    ProAir RespiClick ® is indicated in patients ≥4 years of age for the treatment or prevention of bronchospasm with reversible obstructive airway disease and in patients ≥4 years of age for the …

  3. • Connection to the App, having your Bluetooth turned on, or being near your smartphone is not required for your ProAir Digihaler to work and for you to get your medicine.

  4. PROAIR RESPICLICK can produce paradoxical bronchospasm that may be life threatening. If paradoxical bronchospasm occurs, PROAIR RESPICLICK should be discontinued immediately and …

  5. ProAir RespiClick - HCP Official Website

    ProAir RespiClick® - Official Site for healthcare professionals. Find safety, efficacy, formulary, dosage, prescribing information, and more.

  6. How to Use Albuterol Sulfate Inhaler | ProAir RespiClick®

    Learn how to use breath-activated ProAir RespiClick® inhaler. See full prescribing information including patient information.

  7. ProAir RespiClick - HCP Official Website

    Get ProAir RespiClick resources for your patients, including links to videos, checklists, patient assistance programs, and more.

  8. The safety of PROAIR HFA Inhalation Aerosol in children 4 to 11 years of age is based on one 3-week clinical trial in 50 patients 4 to 11 years of age with asthma using the same formulation of albuterol as …

  9. Childhood Asthma: Signs, Symptoms & Treatment - ProAir

    Find out more about the signs of bronchoconstriction in kids from ProAir RespiClick® (albuterol sulfate). See full prescribing information including patient information.

  10. ProAir HCP

    ProAir RespiClick ® is indicated in patients ≥4 years of age for the treatment or prevention of bronchospasm with reversible obstructive airway disease and in patients ≥4 years of age for the …